التفاصيل البيبلوغرافية
| العنوان: |
476P Open-label phase I/II study evaluating the tolerability and antitumor activity of selinexor (SEL) and pembrolizumab (pembro) in colorectal cancer (CRC) |
| المؤلفون: |
Kutiel, T. Shentzer, Golan, T., Geva, R., Gottfried, M., Zick, A., Shai, A., Dudnik, J., Netiv, E., Yang, F., Sharoni, S., Meng, C., Duic, P., Michel, D., Sbar, E., Shah, J., Kauffman, M.G., Shacham, S., Zer, A. |
| المصدر: |
In Annals of Oncology September 2021 32 Supplement 5:S569-S569 |
| قاعدة البيانات: |
ScienceDirect |
